JC Discovery is a science-driven partner offering a unique combination of know-how from its founding company CIPHE (Center of ImmunoPHEnomics), located in France. With a unique platform and BSL3 laboratory, JC Discovery helps pharma and biotech companies validate their drug candidates with efficient and innovative solutions, early. With decades of experience leading successful translational projects of new mouse model creation and humanization together with high content immunoprofiling, JC Discovery offers strategic custom services to elucidate the mechanisms of action and interactions; identify, validate and prioritize new therapeutic targets in the field of immuno-oncology, inflammatory, autoimmune and infectious diseases. Using a multiomics state-of-the-art technology platform, JC Discovery has also developed innovative approaches of primary T cells editing aiming to optimize drug candidates at an early stage of development with 3Rs in vitro and in vivo dedicated services.